Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Keeping Track: US FDA Clears Another CAR-T And Another Novel ADHD Drug; Submissions Blossom
Apr 05 2021
•
By
Bridget Silverman
Abecma is only the second CBER original approval so far this year.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Approvals
More from Product Reviews